MedDataX Logo

Montreal Toulouse Test With Eye Tracking in Intensive Care Unit to Evaluate Comprehension

NCT ID: NCT05078632

Last Updated: 2021-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

113 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-07

Study Completion Date

2020-09-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assessment of the level of oral comprehension of the intensive care patient is essential to improve their care because they have often troubles like delirium.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Assessment of the level of oral comprehension of the intensive care patient is essential to improve their care because they have often troubles like delirium.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Care

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy volunteers

healthy volunteers

Montreal-Toulouse Test adapted in eye tracking

Intervention Type OTHER

participant pass an eye tracking test to evaluate comprehension

intensive care patient

patient hospitalized in intensive care unit

Montreal-Toulouse Test adapted in eye tracking

Intervention Type OTHER

participant pass an eye tracking test to evaluate comprehension

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Montreal-Toulouse Test adapted in eye tracking

participant pass an eye tracking test to evaluate comprehension

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* French speaker, RASS (Richmond Agitation-sedation scale) between -1 and +1, agree for participation

Exclusion Criteria

* neurovisual disorders
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Tours

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laetitia BODET-CONTENTIN, MD-PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of TOURS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DR190027-MEXICO

Identifier Type: -

Identifier Source: org_study_id